RIVERET Trademark

Trademark Overview


On Monday, September 19, 2016, a trademark application was filed for RIVERET with the United States Patent and Trademark Office. The USPTO has given the RIVERET trademark a serial number of 87175668. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Friday, January 12, 2018. This trademark is owned by Pfizer Inc.. The RIVERET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use; pharmaceutical preparations for the treatment of vaso-occlusive crisis (VOC); pharmaceutical preparations for the treatment of sickle cell disease
riveret

General Information


Serial Number87175668
Word MarkRIVERET
Filing DateMonday, September 19, 2016
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateFriday, January 12, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use; pharmaceutical preparations for the treatment of vaso-occlusive crisis (VOC); pharmaceutical preparations for the treatment of sickle cell disease

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateFriday, January 12, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Friday, January 12, 2018ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Friday, January 12, 2018ABANDONMENT - AFTER PUBLICATION
Thursday, January 11, 2018TEAS EXPRESS ABANDONMENT RECEIVED
Friday, September 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 30, 2017EXTENSION 1 GRANTED
Wednesday, August 30, 2017EXTENSION 1 FILED
Wednesday, August 30, 2017TEAS EXTENSION RECEIVED
Tuesday, April 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, December 24, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 23, 2016ASSIGNED TO EXAMINER
Friday, September 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, September 22, 2016NEW APPLICATION ENTERED IN TRAM